Department of Financial Economics, Pablo de Olavide University, 41013 Seville, Spain.
International Cooperation Andalusian Agency (AACID), Seville 41012, Spain.
Int J Environ Res Public Health. 2018 Mar 30;15(4):639. doi: 10.3390/ijerph15040639.
Clinical risk includes any undesirable situation or operational factor that may have negative consequences for patient safety or capable of causing an adverse event (AE). The AE, intentional or unintentionally, may be related to the human factor, that is, medical errors (MEs). Therefore, the importance of the health-care risk management is a current and relevant issue on the agenda of many public and private institutions. The objective of the management has been evolving from the identification of AE to the assessment of cost-effective and efficient measures that improve the quality control through monitoring. Consequently, the goal of this paper is to propose a Key Risk Indicator (KRI) that enhances the advancement of the health-care management system. Thus, the application of the Value at Risk (VaR) concept in combination to the Loss Distribution Approach (LDA) is proved to be a proactive tool, within the frame of balanced scorecard (BSC), in health organizations. For this purpose, the historical events recorded in the Algo-OpData database (Algorithmics Inc., Toronto, ON, Canada, IBM, Armonk, NY, USA) have been used. The analysis highlights the importance of risk in the financials outcomes of the sector. The results of paper show the usefulness of the Clinical-VaR to identify and monitor the risk and sustainability of the implemented controls.
临床风险包括任何可能对患者安全产生负面影响或导致不良事件（AE）的不良情况或操作因素。AE 可能是故意的，也可能是无意的，与人为因素有关，即医疗差错（MEs）。因此，医疗保健风险管理的重要性是许多公共和私营机构议程上的一个当前和相关问题。管理的目标已经从识别 AE 发展到评估具有成本效益和高效率的措施，通过监测来提高质量控制。因此，本文的目的是提出一个关键风险指标（KRI），以增强医疗保健管理系统的发展。因此，在平衡计分卡（BSC）框架内，将风险价值（VaR）概念与损失分布方法（LDA）结合应用被证明是卫生组织中的一种积极主动的工具。为此，使用了在 Algo-OpData 数据库（Algorithmics Inc.，多伦多，ON，加拿大，IBM，Armonk，NY，美国）中记录的历史事件。该分析强调了风险在该行业财务结果中的重要性。本文的结果表明，Clinical-VaR 可用于识别和监测已实施控制的风险和可持续性。
